TCR Therapy market, Size and Share by 2035

Comments · 452 Views

Growing burden and unaddressed complex treatment needs of cancer patients have paved the way for more effective, safe, and versatile alternatives, such as TCR therapies.

 

Driven by Kimmtrak® approval, promising development pipeline and encouraging clinical trial results, the TCR- based therapy market is anticipated to witness significant growth in the mid to long-term. The financial opportunity within the TCR-based therapy market has been analyzed across the following segments:

 

  • Target Indication(s)
  • Nasopharyngeal Carcinoma
  • Multiple Myeloma
  • Head and Neck Carcinoma
  • Sarcoma, Melanoma
  • Acute Myeloid Leukemia
  • Lung Cancer
  • Ovarian Cancer
  • Merkel Cell Cancer

 

  • Target Antigen
  • NY-ESO-1
  • EBV
  • gp100
  • Others

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World 

 

The Global TCR Therapy Market (2nd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

  • Adaptimmune Therapeutics
  • Alaunos Therapeutics
  • Bristol Myers Squibb
  • Cellular Biomedicine Group
  • Gilead Sciences
  • GlaxoSmithKline
  • Immatics
  • Immunocore
  • Lion TCR
  • Takara Bio
  • Zelluna Immunotherapy

 

Table of Contents

 

  1. Preface      
  2. Executive Summary
  3. Introduction
  4. TCR Therapies: Market Landscape
  5. Popular Target Antigen Analysis
  6. Clinical Trial Analysis
  7. Key Opinion Leaders
  8. TCR-based Therapy Profiles
  9. Partnerships And Collaborations
  10. Funding And Investment Analysis
  11. Patent Analysis
  12. Case Study: Cell Therapy Manufacturing
  13. Cost Price Analysis
  14. Market Forecast and Opportunity Analysis
  15. Promotional Analysis
  16. Company Profiles
  17. Concluding Remarks
  18. Executive Insights
  19. Appendix 1: Tabulated Data
  20. Appendix 2: List of Companies and Organizations

 

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html

 

 

You may also be interested in the following titles:

Cannabis Testing Market

Decentralized Clinical Trials / Virtual Clinical Trials Market 

 

You may also like to learn what our experts are sharing in Roots educational series:

Patient Recruitment – Key Determinant of Successful Clinical Trials

Exploring AI-based Digital Pathology

                       

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

 

Comments